GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (NAS:PROF) » Definitions » Operating Margin %
中文

Profound Medical (Profound Medical) Operating Margin %

: -437.13% (As of Dec. 2023)
View and export this data going back to 2016. Start your Free Trial

Operating Margin % is calculated as Operating Income divided by its Revenue. Profound Medical's Operating Income for the three months ended in Dec. 2023 was $-8.78 Mil. Profound Medical's Revenue for the three months ended in Dec. 2023 was $2.01 Mil. Therefore, Profound Medical's Operating Margin % for the quarter that ended in Dec. 2023 was -437.13%.

Good Sign:

Profound Medical Corp operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Profound Medical's Operating Margin % or its related term are showing as below:

PROF' s Operating Margin % Range Over the Past 10 Years
Min: -775.78   Med: -397.5   Max: -258.25
Current: -397.33


PROF's Operating Margin % is ranked worse than
87.98% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 1.27 vs PROF: -397.33

Profound Medical's 5-Year Average Operating Margin % Growth Rate was 6.00% per year.

Profound Medical's Operating Income for the three months ended in Dec. 2023 was $-8.78 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $-28.62 Mil.


Profound Medical Operating Margin % Historical Data

The historical data trend for Profound Medical's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profound Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -357.07 -258.26 -440.72 -443.08 -397.50

Profound Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -501.03 -367.63 -401.75 -379.63 -437.13

Competitive Comparison

For the Medical Devices subindustry, Profound Medical's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profound Medical Operating Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Profound Medical's Operating Margin % falls into.



Profound Medical Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Profound Medical's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-28.616 / 7.199
=-397.50 %

Profound Medical's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-8.782 / 2.009
=-437.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Profound Medical  (NAS:PROF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Profound Medical Operating Margin % Related Terms

Thank you for viewing the detailed overview of Profound Medical's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Profound Medical (Profound Medical) Business Description

Traded in Other Exchanges
Address
2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.